share_log

中信证券股份有限公司关于《关于灵康药业集团股份有限公司2023年年度报告的信息披露监管工作函》相关问题的核查意见

CITIC Securities Co., Ltd.'s verification opinion on related issues of the information disclosure regulatory letter on Lionco Pharmaceutical Group Co., Ltd.'s 2023 annual report

SZSI ·  Jun 17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more